Akintunde Bello's most recent trade in Xilio Therapeutics Inc was a trade of 62,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xilio Therapeutics Inc | Akintunde Bello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 62,000 | 62,000 | - | - | Stock Option (right to buy) |